Executive Director and Head of Drug Development Solutions North America
Dr. Crowley is the Executive Director and Head of Drug Development Solutions North America at Quotient Sciences, responsible for the design of integrated development programs which leverage Quotient’s pharmaceutical and clinical capabilities to deliver time and cost benefits. He has 18 years of pharma experience in CMC roles ranging from early-stage preformulation through to formulation development and scale-up. His expertise is in selecting and optimizing drug delivery systems based on the physicochemical and biopharmaceutics properties of the drug substance. Dr. Crowley received his Ph.D. in Pharmaceutics from the University of Bradford U.K., completed a post-doc at the University of Wisconsin-Madison, and has worked in both small biotech (AnorMED) and CDMO (Catalent) sectors before joining Quotient in 2013.